XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net Loss $ (11,590,266) $ (14,147,216)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 123,022 88,751
Unrealized loss on marketable securities 18,598 19,895
Stock-based compensation 6,318,562 9,554,582
Gain on PPP loan forgiveness (250,000)
Non-cash lease expense 87,034 87,033
Changes in operating assets and liabilities:    
Accounts receivable (23,300) (40,000)
Prepaid assets and other current assets 37,151 80,135
Accounts payable 56,453 417,674
Accrued expenses and other current liabilities 418,882 (20,321)
Lease liability (102,921) (87,945)
Net cash used in operating activities (4,656,785) (4,297,412)
Cash flows from investing activities:    
Sale of marketable securities 3,690,238
Purchase of marketable securities (437,842) (9,933,562)
Purchases of equipment (101,019) (222,642)
Net cash provided by (used in) investing activities 3,151,377 (10,156,204)
Cash flows from financing activities:    
Net proceeds from issuance of common stock in ATM transactions 411,710
Net proceeds from issuance of common stock in direct offering 1,853,990  
Net cash provided by financing activities 2,265,700
Net increase (decrease) in cash and cash equivalents 760,292 (14,453,616)
Cash and cash equivalents - beginning of period 1,676,577 21,026,727
Cash and cash equivalents - end of period $ 2,436,869 $ 6,573,111